166 related articles for article (PubMed ID: 33385769)
1. Use of an alternative signature peptide during development of a LC-MS/MS assay of plasma nivolumab levels applicable for multiple species.
Ohuchi M; Yagishita S; Taguchi K; Goto Y; Fukahori M; Enoki Y; Shimada T; Yamaguchi M; Matsumoto K; Hamada A
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jan; 1162():122489. PubMed ID: 33385769
[TBL] [Abstract][Full Text] [Related]
2. An LC-MS/MS Method for Absolute Quantification of Nivolumab in Human Plasma: Application to Clinical Therapeutic Drug Monitoring.
Irie K; Okada A; Yamasaki Y; Kokan C; Hata A; Kaji R; Fukushima K; Sugioka N; Okada Y; Katakami N; Fukushima S
Ther Drug Monit; 2018 Dec; 40(6):716-724. PubMed ID: 30048380
[TBL] [Abstract][Full Text] [Related]
3. Validated LC-MS/MS analysis of immune checkpoint inhibitor Nivolumab in human plasma using a Fab peptide-selective quantitation method: nano-surface and molecular-orientation limited (nSMOL) proteolysis.
Iwamoto N; Shimada T; Terakado H; Hamada A
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1023-1024():9-16. PubMed ID: 27155936
[TBL] [Abstract][Full Text] [Related]
4. LC-MS/MS determination of a human mAb drug candidate in rat serum using an isotopically labeled universal mAb internal standard.
Li W; Lin H; Fu Y; Flarakos J
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1044-1045():166-176. PubMed ID: 28113139
[TBL] [Abstract][Full Text] [Related]
5. Validation of a sensitive simultaneous LC-MS/MS method for the quantification of novel anti-cancer thiazolidinedione and quinazolin-4-one derivatives in rat plasma and its application in a rat pharmacokinetic study.
Sengottuvelan S; Uppal R; Vuppu S
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jul; 1121():18-27. PubMed ID: 31082683
[TBL] [Abstract][Full Text] [Related]
6. Quantification of the anti-murine PD-1 monoclonal antibody RMP1-14 in BALB/c mouse plasma by liquid chromatography-tandem mass spectrometry and application to a pharmacokinetic study.
Agrawal K; Hill RC; Wilkinson BL; Allison PB; Thomas CE
Anal Bioanal Chem; 2020 Jan; 412(3):739-752. PubMed ID: 31832706
[TBL] [Abstract][Full Text] [Related]
7. Qualification and application of a liquid chromatography-quadrupole time-of-flight mass spectrometric method for the determination of trastuzumab in rat plasma.
Park MH; Lee MW; Shin YG
Biomed Chromatogr; 2016 Apr; 30(4):625-31. PubMed ID: 26317190
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of an LC-MS/MS Assay to Quantitate 2',4',6'-Trihydroxyacetophenone in Rat and Dog Plasma and its Application to a Pharmacokinetic Study.
Yoo HJ; Hwang SJ; Lee JH; Shim WS; Choi YW; Cho SM; Chung EK; Park JB; Lee KT
Molecules; 2020 Sep; 25(19):. PubMed ID: 32977631
[TBL] [Abstract][Full Text] [Related]
9. Comparison of a stable isotope labeled (SIL) peptide and an extended SIL peptide as internal standards to track digestion variability of an unstable signature peptide during quantification of a cancer biomarker, human osteopontin, from plasma using capillary microflow LC-MS/MS.
Faria M; Halquist MS; Yuan M; Mylott W; Jenkins RG; Karnes HT
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1001():156-68. PubMed ID: 26279007
[TBL] [Abstract][Full Text] [Related]
10. Development of a validated LC-APCI-MS/MS method to study the plasma and tumor distribution of CHO-PTX intravenous lipid emulsion.
Xia X; Song X; Xu J; He J; Peng J; Zhang X; Jin D; Abliz Z; Liu Y
J Pharm Biomed Anal; 2016 Jan; 117():532-43. PubMed ID: 26476881
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a LC-MS/MS assay for quantification of cisplatin in rat plasma and urine.
Shaik AN; Altomare DA; Lesko LJ; Trame MN
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1046():243-249. PubMed ID: 28162967
[TBL] [Abstract][Full Text] [Related]
12. A new reliable, transposable and cost-effective assay for absolute quantification of total plasmatic bevacizumab by LC-MS/MS in human plasma comparing two internal standard calibration approaches.
Legeron R; Xuereb F; Chaignepain S; Gadeau AP; Claverol S; Dupuy JW; Djabarouti S; Couffinhal T; Schmitter JM; Breilh D
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Dec; 1070():43-53. PubMed ID: 29111437
[TBL] [Abstract][Full Text] [Related]
13. Validation and application of a novel LC/MS/MS method for the determination of isoginkgetin in rat plasma.
Zhao C; Han S; Yang S; Xin W
Biomed Chromatogr; 2019 Nov; 33(11):e4667. PubMed ID: 31353500
[TBL] [Abstract][Full Text] [Related]
14. Development of a liquid chromatography/tandem mass spectrometry assay for the quantification of PM01183 (lurbinectedin), a novel antineoplastic agent, in mouse, rat, dog, Cynomolgus monkey and mini-pig plasma.
Pernice T; Bishop AG; Guillen MJ; Cuevas C; Aviles P
J Pharm Biomed Anal; 2016 May; 123():37-41. PubMed ID: 26871278
[TBL] [Abstract][Full Text] [Related]
15. Development of an LC-MS/MS method for quantification of two pairs of isomeric flavonoid glycosides and other ones in rat plasma: Application to pharmacokinetic studies.
Zhang S; Xie Y; Wang J; Geng Y; Zhou Y; Sun C; Wang G
Biomed Chromatogr; 2017 Oct; 31(10):. PubMed ID: 28294360
[TBL] [Abstract][Full Text] [Related]
16. Method development and validation of LC-MS/MS-based assay for the simultaneous quantitation of trastuzumab and pertuzumab in cynomolgus monkey serum and its application in pharmacokinetic study.
Gui LL; Li L; Dong LH; Xiang SS; Zhai JP; Ge ZQ; Song HF
Biomed Chromatogr; 2020 Dec; 34(12):e4903. PubMed ID: 32428305
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of the cyclic peptide GG-8-6 in rat plasma using LC-MS/MS and its application to a pharmacokinetic study.
Chen JT; Guo XM; Yang P; Mu Q
J Pharm Biomed Anal; 2018 Sep; 159():217-223. PubMed ID: 30007177
[TBL] [Abstract][Full Text] [Related]
18. Comparison of conventional liquid chromatography-tandem mass spectrometry versus microflow liquid chromatography-tandem mass spectrometry within the framework of full method validation for simultaneous quantification of 40 antidepressants and neuroleptics in whole blood.
Steuer AE; Poetzsch M; Koenig M; Tingelhoff E; Staeheli SN; Roemmelt AT; Kraemer T
J Chromatogr A; 2015 Feb; 1381():87-100. PubMed ID: 25596763
[TBL] [Abstract][Full Text] [Related]
19. Quantification of nivolumab in human plasma by LC-MS/HRMS and LC-MS/MS, comparison with ELISA.
Millet A; Khoudour N; Bros P; Lebert D; Picard G; Machon C; Goldwasser F; Blanchet B; Guitton J
Talanta; 2021 Mar; 224():121889. PubMed ID: 33379098
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous quantification of rituximab and eculizumab in human plasma by liquid chromatography-tandem mass spectrometry and comparison with rituximab ELISA kits.
Truffot A; Jourdil JF; Seitz-Polski B; Malvezzi P; Brglez V; Stanke-Labesque F; Gautier-Veyret E
Clin Biochem; 2021 Jan; 87():60-66. PubMed ID: 33096054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
